How does Remdesivir attack COVID-19 virus; functioning of antiviral drug explained
Cipla Doubles Remdesivir Production In India For "Unprecedented" Demand The COVID-19 pandemic brought the world to its knees with its sheer virulence and adaptive ability. It forced the scientific community to work at an unprecedented pace to develop therapeutic regimens and vaccines to combat it. As researchers turned to existing drugs with the hopes of tackling the SARS-CoV-2 virus, one drug emerged as a viable candidate— Remdesivir. Now, the drug manufactured by the US-based pharmaceutical company, Gilead Sciences, is being turned to as a savior. Reports emerging from across India have s...
Source: ibtimes.co.in